Gonadotropin-releasing hormone analog

Gonadotropin-releasing hormone analog has been studied in 1 paper since 2026: 1 observational study in people; 1 in the past year. The newest story, Nov 9, 2026: “Menopause symptoms varied widely across 13 countries”.

Intervention

1 paper studies it1 findingUpdated Jun 23, 2026

See all 1 papers on gonadotropin-releasing hormone analog

At a glance

The findings reach people, from one lab or study. 1 lab in 1 country.

“Clinical complexity including endometriosis, disability, long-term conditions, premature ovarian insufficiency, and GnRH analogue use was strongly associated with worse outcomes.”

Physical and mental health impact of perimenopause, menopause and post menopause in a diverse global population (MARIE Project- Global Chapter WP 2a): cross-sectional quantitative data from a mixed-methods studyEClinicalMedicine2026doi:10.1016/j.eclinm.2026.104032

1 lab in 1 country

Funders: Department of Health and Social Care and 1 more

Humans1

What is gonadotropin-releasing hormone analog linked with?

Studies link gonadotropin-releasing hormone analog with menopausal symptom burden.

Menopausal symptom burden

upin humans1

1 study

Gonadotropin-releasing hormone analog is associated with menopausal symptom burden in humans (cross-sectional evaluation across 13 countries).
“Clinical complexity including endometriosis, disability, long-term conditions, premature ovarian insufficiency, and GnRH analogue use was strongly associated with worse outcomes.”
Humanscross-sectional evaluation across 13 countriesfemalesn = 5,228
Menopause symptoms varied widely across 13 countries
EClinicalMedicineJun 23, 2026

Latest

1 paper in 12 months

EClinicalMedicineJul 1

Menopause symptoms varied widely across 13 countries

A cross-sectional survey of 5,228 cisgender and transgender women, with a median age of 55, linked other health conditions to worse symptoms.A cross-sectional survey of 5,228 cisgender and transgender women, with a median age of 55, linked other health conditions to worse symptoms.

Cross-sectional · 5,228 peopleMenopause

Paper